(Q43754973)

26 November 2017

Electrophysiologic effects of a novel selective adenosine A1 agonist (CVT-510) on atrioventricular nodal conduction in humans (English)

1 reference

26 November 2017

B B Lerman

1

1 reference

26 November 2017

K A Ellenbogen

2

1 reference

26 November 2017

A Kadish

3

1 reference

26 November 2017

E Platia

4

1 reference

26 November 2017

K M Stein

5

1 reference

26 November 2017

S M Markowitz

6

1 reference

26 November 2017

S Mittal

7

1 reference

26 November 2017

D J Slotwiner

8

1 reference

26 November 2017

M Scheiner

9

1 reference

26 November 2017

S Iwai

10

1 reference

26 November 2017

L Belardinelli

11

1 reference

26 November 2017

M Jerling

12

1 reference

26 November 2017

R Shreeniwas

13

1 reference

26 November 2017

A A Wolff

14

1 reference

26 November 2017

1 July 2001

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

26 November 2017

1 reference

26 November 2017

6

1 reference

26 November 2017

3

1 reference

26 November 2017

237-245

1 reference

Cardiac electrophysiology of adenosine. Basic and clinical concepts

26 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F107424840100600304

Effect of adenosine on atrioventricular conduction. I: Site and characterization of adenosine action in the guinea pig atrioventricular node.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840100600304

Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840100600304

A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840100600304

Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840100600304

Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840100600304

Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840100600304

Effects of intravenous diltiazem on rapid atrial fibrillation accompanied by congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840100600304

Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840100600304

Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840100600304

Electrophysiologic effects of adenosine in patients with supraventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840100600304

Purinergic inhibition of neurotransmitter release in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840100600304

A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840100600304

10.1177/107424840100600304

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference